Nuo Therapeutics Statistics
Total Valuation
AURX has a market cap or net worth of 101.45 million. The enterprise value is 101.05 million.
| Market Cap | 101.45M |
| Enterprise Value | 101.05M |
Important Dates
The last earnings date was Friday, October 31, 2025.
| Earnings Date | Oct 31, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AURX has 48.08 million shares outstanding. The number of shares has increased by 6.37% in one year.
| Current Share Class | 48.08M |
| Shares Outstanding | 48.08M |
| Shares Change (YoY) | +6.37% |
| Shares Change (QoQ) | +1.53% |
| Owned by Insiders (%) | 48.00% |
| Owned by Institutions (%) | 2.14% |
| Float | 20.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 38.85 |
| PB Ratio | -241.77 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -41.58 |
| EV / Sales | 38.69 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -86.78 |
Financial Position
The company has a current ratio of 1.16
| Current Ratio | 1.16 |
| Quick Ratio | 0.93 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.10 |
| Interest Coverage | -18,332.46 |
Financial Efficiency
Return on equity (ROE) is -1,032.50% and return on invested capital (ROIC) is -419.49%.
| Return on Equity (ROE) | -1,032.50% |
| Return on Assets (ROA) | -87.97% |
| Return on Invested Capital (ROIC) | -419.49% |
| Return on Capital Employed (ROCE) | -382.41% |
| Revenue Per Employee | 290,172 |
| Profits Per Employee | -270,045 |
| Employee Count | 9 |
| Asset Turnover | 1.43 |
| Inventory Turnover | 4.19 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +177.87% in the last 52 weeks. The beta is -1,045.18, so AURX's price volatility has been lower than the market average.
| Beta (5Y) | -1,045.18 |
| 52-Week Price Change | +177.87% |
| 50-Day Moving Average | 2.20 |
| 200-Day Moving Average | 1.66 |
| Relative Strength Index (RSI) | 42.72 |
| Average Volume (20 Days) | 3,603 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.01 |
Income Statement
In the last 12 months, AURX had revenue of 2.61 million and -2.43 million in losses. Loss per share was -0.05.
| Revenue | 2.61M |
| Gross Profit | 1.84M |
| Operating Income | -2.57M |
| Pretax Income | -2.43M |
| Net Income | -2.43M |
| EBITDA | -2.49M |
| EBIT | -2.57M |
| Loss Per Share | -0.05 |
Balance Sheet
The company has 514,797 in cash and 114,692 in debt, giving a net cash position of 400,105 or 0.01 per share.
| Cash & Cash Equivalents | 514,797 |
| Total Debt | 114,692 |
| Net Cash | 400,105 |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | -419,606 |
| Book Value Per Share | -0.01 |
| Working Capital | 206,167 |
Cash Flow
In the last 12 months, operating cash flow was -932,864 and capital expenditures -231,551, giving a free cash flow of -1.16 million.
| Operating Cash Flow | -932,864 |
| Capital Expenditures | -231,551 |
| Free Cash Flow | -1.16M |
| FCF Per Share | -0.02 |
Margins
Gross margin is 70.38%, with operating and profit margins of -98.28% and -93.06%.
| Gross Margin | 70.38% |
| Operating Margin | -98.28% |
| Pretax Margin | -93.06% |
| Profit Margin | -93.06% |
| EBITDA Margin | -95.48% |
| EBIT Margin | -98.28% |
| FCF Margin | n/a |
Dividends & Yields
AURX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.37% |
| Shareholder Yield | -6.37% |
| Earnings Yield | -2.40% |
| FCF Yield | -1.15% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AURX has an Altman Z-Score of -11.04 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -11.04 |
| Piotroski F-Score | 2 |